Top

Published in:

01-08-2012

Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases

Authors: Si-Long Hu, Zheng-Rong Zhou, Ying-Jian Zhang

Published in: Abdominal Radiology | Issue 4/2012

Abstract

Two cases of postoperative female patients with ovarian serous papillary carcinoma were referred for F-18 Fluorodeoxyglucose (F-18 FDG) PET/CT to evaluate suspicious recurrence and/or metastasis. One patient presented with multiple extensive calcified lesions with increased FDG uptake in the abdominopelvic cavity and the series of PET/CT scans showed progression of disease after chemotherapy. The other patient presented with three calcified masses with intensive uptake of FDG located in the left pelvis, the right subphrenic region, and the right supradiaphragmatic area, respectively. These suggest that F-18 FDG PET/CT can be useful in identifying malignant calcification and assessing therapeutic response of calcified malignancy.

Burkill GJ, Allen SD, A’Hern RP, et al. (2009) Significance of tumour calcification in ovarian carcinoma. Br J Radiol 82:640–644. doi:10.1259/bjr/12716831 PubMedCrossRef

Mitchell DG, Hill MC, Hill S, Zaloudek C (1986) Serous carcinoma of the ovary: CT identification of metastatic calcified implants. Radiology 158:649–652PubMed

Franchi M, La Fianza A, Babilonti L, et al. (1990) Serous carcinoma of the ovary: value of computed tomography in detection of calcified pleural and pulmonary metastatic implants. Gynecol Oncol 39:85–88PubMedCrossRef

Nam EJ, Yun MJ, Oh YT, et al. (2010) Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI. Gynecol Oncol 116:389–394. doi:10.1016/j.ygyno.2009.10.059 PubMedCrossRef

Weir MM, Bell DA, Young RH (1998) Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors. Am J Surg Pathol 22:849–862PubMedCrossRef

Meyers MA (2005) Dynamic radiology of the abdomen: normal and pathologic anatomy, 5th edn. New York: Springer

Meyers MA (1970) The spread and localization of acute intraperitoneal effusions. Radiology 95:547–554PubMed

Meyers MA (1973) Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119:198–206PubMed

Meyers MA (1975) Metastatic seeding along the small bowel mesentery. Roentgen features. Am J Roentgenol Radium Ther Nucl Med 123:67–73PubMed

10.

Chou CK, Liu GC, Su JH, et al. (1994) MRI demonstration of peritoneal implants. Abdom Imaging 19:95–101PubMedCrossRef

11.

Forstner R, Hricak H, White S (1995) CT and MRI of ovarian cancer. Abdom Imaging 20:2–8PubMedCrossRef

12.

Funicelli L, Travaini LL, Landoni F, et al. (2010) Peritoneal carcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT. Abdom Imaging 35:701–707. doi:10.1007/s00261-009-9578-8 PubMedCrossRef

13.

Gontier E, Wartski M, Guinebretiere JM, Alberini JL (2006) 18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma. AJR Am J Roentgenol 187:W285–W289. doi:10.2214/AJR.05.1483 PubMedCrossRef

14.

Tiro AV, Talukdar R, Lewis MG (2009) A unique case of serous psammocarcinoma of the ovary presenting with pleural effusion and manifesting psammoma body implants in the pleural cavity and pericardium. Gynecol Oncol 113:402–404. doi:10.1016/j.ygyno.2009.03.008 PubMedCrossRef

Title: Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases
Authors: Si-Long Hu
Zheng-Rong Zhou
Ying-Jian Zhang
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: Abdominal Radiology / Issue 4/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-011-9800-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Severe intestinal ischemia as a presenting feature of metastatic ileal carcinoid tumor: role of MDCT with coronal reformation in the early diagnosis

Giant fibrovascular polyp of the esophagus—imaging techniques for proper treatment planning: report of two cases

Radical prostatectomy: value of prostate MRI in surgical planning

Hepatocellular carcinoma: clinical and radiological findings in patients with chronic B viral hepatitis and chronic C viral hepatitis

Esophageal cancer characterization with pneumo-64-MDCT

Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials